Yong Fu Chen
Director of Finance/CFO at Shenyang Sunshine Pharmaceuticals Co., Ltd.
Yong Fu Chen active positions
| Companies | Position | Start | End |
|---|---|---|---|
Hongkong Sansheng Medical Ltd.
 Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Director/Board Member | 01/11/2014 | - |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Director of Finance/CFO | 01/03/2003 | - |
Career history of Yong Fu Chen
Former positions of Yong Fu Chen
| Companies | Position | Start | End |
|---|---|---|---|
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Director/Board Member | 01/08/2018 | 24/08/2022 |
Training of Yong Fu Chen
| Liaoning University | Undergraduate Degree |
Statistics
International
| China | 4 |
| Hong Kong | 2 |
Operational
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
| Director of Finance/CFO | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Health Technology |
| Private companies | 2 |
|---|---|
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Health Technology |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
- Stock Market
- Insiders
- Yong Fu Chen
- Experience
